Multiple Manufacturers

DEXRAZOXANE

Manufacturer:

Multiple Manufacturers

Dexrazoxane HCPCS:

J1190

HCPCS Code Descriptor:

Injection, dexrazoxane hydrochloride, per 250 mg

Category:

J Code

Dexrazoxane NDCs:

51991-0942-98, 67457-0208-50, 55150-0437-01, 00143-9248-01, 76310-0110-01, 72266-0101-01, 47781-0578-07, 72611-0716-01, 67457-0207-25, 55150-0434-02, 55150-0434-01, 00143-9247-01, 72266-0235-01, 72611-0716-72

Primary Type:

Unclassified

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67457-0208-50, 76310-0110-01, 47781-0578-07, 67457-0207-25

About Dexrazoxane:

DEXRAZOXANE is an Unclassified drug manufactured by Mylan and administered via the Intravenous route of administration. The J Code: J1190 is aligned to the drug DEXRAZOXANE.

ACCESS PRICING AND MORE BY REGISTERING

J1190 Added Date:

January 1, 1997

J1190 Effective Date:

January 1, 1997

J1190 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dexrazoxane billing and coding information.
Our team did not identify a source for Dexrazoxane patient assistance information. Please reach out to our team if you feel that this is a mistake.
DEXRAZOXANE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for DEXRAZOXANE. Please check back in a few weeks.